Assero, MB - financials and debts

Company age: 6 y. 7 mo.

Update

Assero - Company finances

EUR
2020
From: 2020-02-28
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 2,293 10,217 22,550 44,520 65,000 99,015
Profit before tax 1,234 672 -893 -391 19,919 51,273
Net profit 1,234 707 -912 -391 18,887 48,197
Equity 1,234 1,871 959 568 19,455 53,652
Liabilities - - 0 0 2,764 4,802
Non-current assets 0 0 0 0 0 0
Current assets 32,219 17,876 959 568 22,219 58,454
Total assets 32,219 17,876 959 568 22,219 58,454
Taxes paid
STI taxes - - - - 8,888 21,829
Financial indicators
Revenue change y/y - +345.6% +120.7% +97.4% +46.0% +52.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 3.8% 4.0% -95.1% -68.8% 85.0% 82.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 100.0% 37.8% -95.1% -68.8% 97.1% 89.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 53.8% 6.9% -4.0% -0.9% 29.1% 48.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 53.8% 6.6% -4.0% -0.9% 30.6% 51.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - 0.1 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 573 2,554 5,638 - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Assero - Social security debts

The company had no debts to Sodra

Assero - VMI tax arrears

From To Overdue, €
2025-06-28 2025-07-25 0.26
2024-11-01 2024-11-25 0.98

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Assero, MB (code 305485966) is a small partnership engaged in research and development in medical sciences. In 2025, the company generated revenue of €99.0K, up 52.3% year on year and 122.4% over two years, showing a clear expansion in operating scale. Net profit rose to €48.2K in 2025 from €18.9K in 2024, while the company moved from a small loss of €391 in 2023 to sustained profitability. The profit margin improved from -0.9% in 2023 to 29.1% in 2024 and 48.7% in 2025, indicating stronger operating efficiency. Total assets reached €58.5K at the end of 2025, supported by equity of €53.7K and liabilities of €4.8K. The equity ratio was 91.8% and debt-to-equity stood at 0.09, pointing to a very conservative balance sheet. Return on equity was 89.8% and return on assets 82.5%, while asset turnover was 1.69x. Revenue per employee cannot be assessed from the available data.